Weill Cornell Bone Marrow and Stem Cell Transplant

06/04/2026

04/09/2026

What is tumor-infiltrating lymphocyte (TIL) therapy? In this episode of the CancerCast podcast, Dr. Barbara Ma talks about this new form of cellular immunotherapy leveraging the body’s immune system and specialized cells called T-lymphocytes. TIL is currently approved by the U.S. Food and Drug Administration (FDA) for metastatic melanoma with ongoing research in other types of cancer. Learn more about how this treatment works and how it differs from other cell therapies: https://bit.ly/4nIIM8z

03/06/2026

Watch: Dr. Alexandra Gomez spoke about Orca-T for the prevention of graft-versus-host disease (GVHD) in patients with myelodysplastic syndromes (MDS) and acute undergoing transplant:

Alexandra Gomez Arteaga, MD, of Weill Cornell Medicine, discussed results from the Precision-T trial, which studied Orca-T for the prevention of graft-versus-host disease.

02/13/2026

We’re excited that Dr. George Coukos, an internationally renowned expert on immunology, is launching the Ludwig Laboratory for Cell Therapy Weill Cornell Medicine. This lab will be developing next generation T-cell therapies for patients with cancer.

Dr. George Coukos, an internationally renowned expert on cancer immunology, is launching the Ludwig Laboratory for Cell Therapy at Weill Cornell Medicine.

12/18/2025

WATCH: Dr. Alexandra Gomez spoke with VuMedi about outcomes after allogeneic HCT in patients with acute myeloid ( ) with a TP53 alteration

11/05/2025

Watch Dr. Alexandra Gomez talk about how allogeneic stem cell transplantation for acute lymphoblastic (ALL) has evolved with the introduction of other novel therapies:

Alexandra Gomez-Arteaga, MD, Weill Cornell Medicine, New York, NY, briefly discusses how the role of allogeneic stem cell transplantation (alloSCT)...

10/28/2025

Dr. Alexandra Gomez chatted with Oncology Learning Network at about the role of transplant for patients with acute lymphoblastic (ALL):

Alexandra Gomez Arteaga, MD, shares insights into which patients with acute lymphoblastic leukemia should be considered for transplant, including those failing to meet MRD negativity or who have a higher genomic risk.

03/04/2024

After Laila Hardy-Johnson found out she was pregnant, she did not expect to receive an accompanying diagnosis of leukemia. Though the news came as a shock, Laila had already faced this disease once before, nearly a decade earlier.

06/13/2023

Join us in officially welcoming Dr. Anna Alperovich who joined our Weill Cornell Medicine/NewYork-Presbyterian Hospital BMT team this Spring. She cares for patients in need of stem cell transplants or cellular therapy: https://bit.ly/3qFvQbz